NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/08/2025
Back to search
Official data from USPTO
OXB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
04/03/2026
Trademark type
Combined
Nice classes
40, 42
Filing date
06/18/2024
Registration date
07/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/08/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
84
Owner location
Oxford, GB
Examiner
SPARHAWK, JESSICA LEA
Law office
T30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the letters "OXB". The top right of the letter "X" is connected to the top left of the letter "B". A double helix design is to the right of the letters "OXB".
Holders and representatives
Holders
Oxford BioMedica plc
Representatives
Rebeccah Gan MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom and contract manufacture of products relating to biotechnologygene therapyviralretrovirallentiviral and non-viral preparations and biopharmaceutical productsviral and non-viral vectorsvaccines
Class 42
Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnologygene therapy and vector-based delivery systems; productviral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnologygene therapyvector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2025
PUBO
PUBLISHED FOR OPPOSITION
05/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/14/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/16/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/16/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/16/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/18/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2025
GNRT
NON-FINAL ACTION E-MAILED
01/24/2025
CNRT
NON-FINAL ACTION WRITTEN
01/24/2025
DOCK
ASSIGNED TO EXAMINER
01/13/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/12/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2025
NWAP
NEW APPLICATION ENTERED
06/18/2024
Continuous trademark protection
Get notified about every new filing that threatens OXB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.